Context-dependent TGFβ family signalling in cell fate regulation

L Richardson, SG Wilcockson, L Guglielmi… - … Reviews Molecular Cell …, 2023 - nature.com
The transforming growth factor-β (TGFβ) family are a large group of evolutionarily conserved
cytokines whose signalling modulates cell fate decision-making across varying cellular …

BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension

I Cuthbertson, NW Morrell, P Caruso - Circulation research, 2023 - Am Heart Assoc
Pulmonary arterial hypertension forms the first and most severe of the 5 categories of
pulmonary hypertension. Disease pathogenesis is driven by progressive remodeling of …

[HTML][HTML] Pathophysiology and new advances in pulmonary hypertension

S Bousseau, RS Fais, S Gu, A Frump, T Lahm - BMJ medicine, 2023 - ncbi.nlm.nih.gov
Pulmonary hypertension is a progressive and often fatal cardiopulmonary condition
characterised by increased pulmonary arterial pressure, structural changes in the pulmonary …

Molecular insight into the therapeutic effects of stem cell-derived exosomes in respiratory diseases and the potential for pulmonary delivery

MH Azhdari, N Goodarzi, M Doroudian… - International Journal of …, 2022 - mdpi.com
Respiratory diseases are the cause of millions of deaths annually around the world. Despite
the recent growth of our understanding of underlying mechanisms contributing to the …

Novel mechanisms targeted by drug trials in pulmonary arterial hypertension

DF Condon, S Agarwal, A Chakraborty, N Auer… - Chest, 2022 - Elsevier
Pulmonary arterial hypertension (PAH) is a rare disease associated with abnormally
elevated pulmonary pressures and right heart failure resulting in high morbidity and …

Therapeutic approaches for treating pulmonary arterial hypertension by correcting imbalanced TGF-β superfamily signaling

P Andre, SR Joshi, SD Briscoe, MJ Alexander… - Frontiers in …, 2022 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a rare disease characterized by high blood
pressure in the pulmonary circulation driven by pathological remodeling of distal pulmonary …

Insights into bone morphogenetic proteins in cardiovascular diseases

D Ye, Y Liu, H Pan, Y Feng, X Lu, L Gan… - Frontiers in …, 2023 - frontiersin.org
Bone morphogenetic proteins (BMPs) are secretory proteins belonging to the transforming
growth factor-β (TGF-β) superfamily. These proteins play important roles in embryogenesis …

Pulmonary hypertension in association with lung disease: quantitative CT and artificial intelligence to the rescue? State-of-the-art review

K Dwivedi, M Sharkey, R Condliffe, JM Uthoff, S Alabed… - Diagnostics, 2021 - mdpi.com
Accurate phenotyping of patients with pulmonary hypertension (PH) is an integral part of
informing disease classification, treatment, and prognosis. The impact of lung disease on PH …

Novel molecular mechanisms involved in the medical treatment of pulmonary arterial hypertension

I Martin de Miguel, A Cruz-Utrilla, E Oliver… - International Journal of …, 2023 - mdpi.com
Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate
despite advances in diagnostic and therapeutic strategies. In recent years, significant …

Pulmonary hypertension and insulin resistance: a mechanistic overview

TM Zanotto, AESS Gonçalves, MJA Saad - Frontiers in Endocrinology, 2024 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a vascular remodeling disease, characterized by
increased blood pressure levels in pulmonary circulation, leading to a restriction in the …